, Tracking Stock Market Picks
Enter Symbol:
Genvec, Inc. (GNVC) [hlAlert]

up 210.38 %

Genvec, Inc. (GNVC) rated Buy by Merriman

Posted on: Friday,  Oct 2, 2009  8:25 AM ET by Merriman

Merriman rated Buy Genvec, Inc. (NASDAQ: GNVC) on 10/02/2009, when the stock price was $0.80. Since
then, Genvec, Inc. has gained 210.39% as of 08/27/2015's recent price of $2.48.
If you would have followed this Merriman's recommendation on GNVC, you would have gained 210.38% of your investment in 2155 days.

GenVec, Inc. is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. Each of the Company's product candidates uses patent-protected technology to deliver genes that produce beneficial proteins. GenVec's lead product, TNFerade is currently in a pivotal Phase II/III study in locally advanced pancreatic cancer; Phase II studies are in progress in rectal cancer and metastatic melanoma; and Phase I/II studies are in progress in head and neck cancer. GenVec also uses its proprietary adenovector technology to develop vaccines for infectious diseases including HIV, malaria, seasonal and pandemic flu, and foot-and-mouth disease.

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/2/2009 8:25 AM Buy
as of 12/31/2009
1 Week down  -48.21 %
1 Month down  -44.76 %
3 Months down  -27.40 %
1 YTD down  -27.40 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy